Skip to content

Pranayama for Posttraumatic Stress Disorder

Pranayama for Outpatients With Posttraumatic Stress Disorder: a Randomized-controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05645588
Acronym
PRANAPTSD
Enrollment
0
Registered
2022-12-09
Start date
2025-01-01
Completion date
2028-02-01
Last updated
2025-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Traumatic Stress Disorder

Keywords

Posttraumatic Stress Disorder, Pranayama, Yoga, Complimentary Therapies, Somatic Symptom Disorder, SSD, PTSD, Safety, Effectiveness, Randomized Controlled Trail

Brief summary

This study aims to investigate the effect of pranayama (yoga-breathing techniques) on post-traumatic symptom severity in patients with post-traumatic stress disorder undergoing standard, out-patient, trauma-focused psychotherapy. Therefore, short pranayama sessions of 5-10 minutes will be provided to the patients directly at the begin of each of psychotherapy unit, while the control group will receive standard, trauma-focused psychotherapy alone.

Interventions

BEHAVIORALPranayama assisted trauma-focused standard psychotherapy (TF-SPT)

To prepare patients for the TF-SPT, they received 5-10 minutes of pranayama at the begin of each of the 10 TF-SPT units.

BEHAVIORALTrauma-focused standard psychotherapy (TF-SPT)

Patients wait for 10 TF-SPT units and then are offered to learn pranayama

Sponsors

Universität Duisburg-Essen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Participants and Therapists (Care Provider) could not be blinded according to the nature of the intervention. However, therapists will be blinded to allocation concealment as they do not be aware of the patients' group assignment at baseline assessment until they open the opaque randomization envelope, which contains the patient randomization number and group assignment. The random sequence generation and the envelopes were prepared by the study coordinator who is not involved patient recruitment. Patients received post intervention questionnaires from a study assistant/nurse of the respective outpatient department (outcome assessor) who is also blinded to the patients' group assignment. After completing the questionnaires, the study assistant will sent them to study coordinator so that the therapist could not influence the patients' answers.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed PTSD according to ICD-10 F43.1 * PCL-5 Score of at least 33 points * Undergoing outpatient standard trauma-focused psychotherapy (Cognitive Behavioral Therapy, Psychodynamic Psychotherapy, or Systemic Psychotherapy)

Exclusion criteria

* Pre-existing mental or somatic conditions that are unlikely to result in correct or safe performance of pranayama: 1. Substance dependence current use (ICD-10 F10.X, F11.X). 2. Dementia (ICD-10 F00-F03) 3. Somatoform Disorder (ICD F45.X) of moderate or severe degree according to DSM-5 300.82: ≥ 2 reactions (cognitive, emotional, or behavioral) to somatic symptoms (≥ 2 criterion-B) 4. Severe cardiovascular disease: presence of cardiac or vascular implants or grafts, e.g., pacemaker (ICD-10 Z95.X), condition after organ or tissue transplantation (ICD-10 Z94.X) 5. Acute adverse events occurring during pranayama at baseline (including neck pain, subjective sensation of pressure in the lungs, anxiety / panic) * Cancer diagnosis in the past 5 years (ICD-10 C00-C97, D37-48) * Pregnancy / breastfeeding * Regular pranayama practice in the last 12 months

Design outcomes

Primary

MeasureTime frameDescription
Intensity of posttraumtic symptomsweek 10Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): The PCL-5 is a standard 20-item scale with a sum score ranging from 0 to 80 points. The cut-off point for clinically relevant symptom severity is 33 points.

Secondary

MeasureTime frameDescription
Anxietyweek 10Beck Anxiety Inventory (BAI): The BAI is a standard 21-items scale ranging from 0 to 63 points with 0-7 points = minimal anxiety, 8-15 points = mild anxiety, 16-25 points = moderate anxiety, and 26-63 points = clinically relevant anxiety.
Depressionweek 10Beck Depression Inventory Revision (BDI-II): The BDI-II is a standard 21-items scale ranging from 0 to 63 points with 0-13 points =no/clinically not relevant depression/depression in remission, 14-19 points = mild depression, 20-28 points = moderate depression und 29-63 points = severe depression.
Breath Holding Durationweek 10Breath Holding Task (BHT): The BHT is standard test procedure for the measurement of ability of the suppression of the respiratory reflex.
Adverse Eventsweeks 1,2,3,4,5,6,7,8,9,10Number of patients with adverse events and types of the adverse events
Therapist Global Improvementweek 10Clinician Global Impression of Improvement (CGI-I) rated by the therapist on 1 item ranging from 1 to 7.
Patient Global Improvementweek 10Patient Global Impression of Improvement (PGI-I) rated by the patient on 1 item ranging from 1 to 7.
Health-related quality of lifeweek 10Short Form 12 Health Survey (SF-12): The SF-12 is a standard 12-item scale with two sum scores (physical and mental quality of life) ranging from 0 to 100 points.

Other

MeasureTime frameDescription
Social Readjustment after life eventsweeks 0+10Social Readjustment Rating Scale (SRRS): The SRRS consists of 43 items. A sum score of 1-149 = low stress level; 150-299 = 30% probability of developing a stress-associated disease; 300 and more = 80% probability of developing a stress-associated disease.
Complianceweeks 0,1,2,3,4,5,6,7,8,9,10Diary (via App): daily pranayama practice, BHT time
Medicationweeks 0+10A change in medication between weeks 0 and 10 is recorded.
Interoceptive Awarenessweeks 0+10Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-II): The MAIA-II is a 37-item questionnaire. It includes 8 subscales. Scores ranged between 0 and 5, where higher score indicate more awareness of bodily sensation. Percentiles can also be calculated, indicating how the score is associated to a normative sample.
Treatment Expectationweek 0Treatment Credibility Scale (TCS): The TCS is a standard NRS scale ranging from 0 points (lowest expectation of treatment effectiveness) to 10 points (highest expectation of treatment effectiveness).

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026